|
Characteristics
|
Low-grade group
|
Moderate-grade group
|
t/Z/x2
|
p-Value
|
Cohen’s d/ Cramér’s V/ r_rb
|
|---|---|---|---|---|---|
|
Age(years)
|
31.49 ± 4.15
|
32.91 ± 3.65
|
0.895
|
0.3461
|
0.37
|
|
Postpartum BMI(kg/m2)
|
23.38 ± 2.33
|
23.92 ± 2.54
|
1.729
|
0.1901
|
0.22
|
|
Delivery mode
|
|||||
|
Vaginal delivery
|
61(84.7%)
|
85(89.5%)
|
0༎841
|
0.3593
|
0.07
|
|
Forceps delivery
|
11(15.3)༉
|
10(10.5%)
|
|||
|
Parity
|
|||||
|
1
|
49(68.1%)
|
47(49.5%)
|
0.23
|
||
|
2
|
22(30.6%)
|
38(40%)
|
8.669
|
0.0133
|
|
|
3
|
1(1.4%)
|
10(10.5%)
|
|||
|
Fetal weight(kg)
|
3.20 ± 0.35
|
3.33 ± 0.39
|
-1.895
|
0.0582
|
0.17
|
| Note: | |||||
| BMI- body mass index, | |||||
| 1Student's t-test, | |||||
| 2Mann-Whitney U test, | |||||
| 3Chi-square test. | |||||
| All statistical tests are accompanied by p-values to indicate the level of statistical significance, with p < 0.05 considered statistically significant. | |||||
|
Variable
|
Group
|
Pre-treatment (Mean ± SD)
|
Post-treatment (Mean ± SD)
|
Within-group P¹
|
Z
|
Cohen’s d/r_rb
|
Change (Δ, Mean ± SD)
|
Between-group P²
|
Z
|
Cohen’s d/r_rb
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Modified Oxford Scale
|
Low-grade group
|
0.89 ± 0.57
|
2.60 ± 0.94
|
<0.0012
|
-7.31
|
0.86
|
1.72 ± 0.78
|
0.0744
|
-1.79
|
0.16
|
|
Moderate-grade group
|
2.39 ± 0.46
|
3.90 ± 0.61
|
<0.0012
|
-8.47
|
0.87
|
1.51 ± 0.62
|
||||
|
POP-Q
|
||||||||||
|
Aa
|
Low-grade group
|
-1.24 ± 0.82
|
-2.01 ± 0.79
|
<0.0012
|
-6.73
|
0.79
|
-0.78 ± 0.58
|
0.1834
|
-1.33
|
0.12
|
|
Moderate-grade group
|
-0.93 ± 0.79
|
-1.56 ± 0.79
|
<0.0012
|
-7.03
|
0.72
|
-0.64 ± 0.56
|
||||
|
Ap
|
Low-grade group
|
-2.88 ± 0.38
|
-2.94 ± 0.24
|
0.1012
|
-1.64
|
0.19
|
-0.06 ± 0.30
|
0.7654
|
-0.30
|
0.02
|
|
Moderate-grade group
|
-2.71 ± 0.55
|
-2.78 ± 0.50
|
0.1122
|
-1.59
|
0.16
|
-0.07 ± 0.46
|
||||
|
Ba
|
Low-grade group
|
-1.24 ± 0.82
|
-2.01 ± 0.79
|
<0.0012
|
-6.73
|
0.79
|
-0.78 ± 0.58
|
0.1834
|
-1.33
|
0.12
|
|
Moderate-grade group
|
-0.91 ± 0.82
|
-1.56 ± 0.79
|
<0.0012
|
-7.03
|
0.72
|
-0.64 ± 0.56
|
||||
|
Bp
|
Low-grade group
|
-2.88 ± 0.38
|
-2.93 ± 0.24
|
0.1012
|
-1.64
|
0.19
|
-0.06 ± 0.30
|
0.7654
|
-0.30
|
0.02
|
|
Moderate-grade group
|
-2.68 ± 0.58
|
-2.78 ± 0.50
|
0.1122
|
-1.59
|
0.16
|
-0.07 ± 0.46
|
||||
|
C
|
Low-grade group
|
-5.45 ± 0.91
|
-5.94 ± 0.33
|
<0.0012
|
-4.52
|
0.53
|
-0.49 ± 0.83
|
0.1234
|
-1.54
|
0.13
|
|
Moderate-grade group
|
-5.10 ± 1.07
|
-5.78 ± 0.62
|
<0.0012
|
-5.73
|
0.59
|
-0.68 ± 0.92
|
||||
|
D
|
Low-grade group
|
-7.16 ± 0.59
|
-6.96 ± 1.83
|
0.8402
|
-0.20
|
0.02
|
0.02 ± 0.55
|
0.3334
|
-0.97
|
0.08
|
|
Moderate-grade group
|
-6.91 ± 0.68
|
-7.01 ± 0.43
|
0.0842
|
-1.73
|
0.18
|
-0.11 ± 0.66
|
||||
| Notes: | ||||||||||
| Within-group comparisons were performed using the paired-samples t-test¹ or Wilcoxon signed-rank test2, as appropriate. | ||||||||||
| Between-group comparisons were performed using the independent-samples t-test3 or Mann–Whitney U test4, comparing post-treatment changes (Δ = Post treatment–Pre treatment ). | ||||||||||
| Effect sizes were calculated using the rank-biserial correlation (r_rb) or Cohen’s d, or Cramér’s V. All statistical tests were two-tailed, and a P value < 0.05 was considered statistically significant. | ||||||||||
|
Variable
|
Group
|
Pre-treatment (Mean ± SD)
|
Post-treatment (Mean ± SD)
|
Within-group P¹
|
Z
|
Cohen’s d/
|
Change (Δ, Mean ± SD)
|
Between-group P²
|
Z/t
|
Cohen’s d/ r_rb
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Pre-baseline mean value(uV)
|
Low-grade group ( 63)
|
5.19 ± 3.27
|
4.46 ± 2.46
|
0.0212
|
-2.31
|
0.27
|
-0.72 ± 2.57
|
0.0953
|
1.22
|
0.26
|
|
Moderate-grade group 63)
|
5.07 ± 2.94
|
3.60 ± 2.47
|
<0.0012
|
-4.35
|
0.45
|
-1.47 ± 3.03
|
||||
|
Flick contraction maximum value(uV)
|
Low-grade group
|
22.26 ± 9.92
|
31.67 ± 12.02
|
<0.0012
|
-6.10
|
0.72
|
9.41 ± 10.85
|
-0.8134
|
0.42
|
0.07
|
|
Moderate-grade group
|
35.87 ± 14.74
|
44.21 ± 15.61
|
<0.0012
|
-5.70
|
0.59
|
8.34 ± 12.77
|
||||
|
Tonic contraction mean value(uV)
|
Low-grade group
|
14.67 ± 7.53
|
22.68 ± 8.71
|
<0.0012
|
-6.69
|
0.79
|
8.01 ± 8.38
|
0.1324
|
-1.51
|
0.14
|
|
Moderate-grade group
|
23.38 ± 10.16
|
33.32 ± 10.64
|
<0.0012
|
-7.46
|
0.77
|
9.95 ± 9.63
|
||||
|
Endurance contraction mean value(uV)
|
Low-grade group
|
13.10 ± 6.93
|
19.86 ± 7.28
|
<0.0012
|
-6.38
|
0.75
|
6.76 ± 7.44
|
0.6354
|
-0.48
|
0.04
|
|
Moderate-grade group
|
20.29 ± 9.64
|
27.46 ± 9.18
|
<0.0012
|
-6.34
|
0.65
|
7.18 ± 9.81
|
||||
|
Post-baseline mean value(uV)
|
Low-grade group
|
4.71 ± 4.16
|
5.18 ± 2.95
|
0.0162
|
-2.41
|
0.28
|
0.47 ± 4.12
|
0.2464
|
-1.16
|
0.11
|
|
Moderate-grade group
|
4.42 ± 2.87
|
4.79 ± 2.95
|
0.1852
|
-1.33
|
0.14
|
0.37 ± 2.94
|
||||
| Notes: | ||||||||||
| Within-group comparisons were performed using the paired-samples t-test¹ or Wilcoxon signed-rank test2, as appropriate. | ||||||||||
| Between-group comparisons were performed using the independent-samples t-test3 or Mann–Whitney U test4, comparing post-treatment changes (Δ = Post treatment – Pre treatment ). | ||||||||||
| Effect sizes were calculated using the rank-biserial correlation (r_rb) or Cohen’s d, or Cramér’s V. All statistical tests were two-tailed, and a P value < 0.05 was considered statistically significant. | ||||||||||